chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer and described the occurrence of the throat closing in a 4 year old male pt who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix). A physician or other health care professional has not verified this report. On 03Dec2003, the pt received the fifth dose of Infanrix. On the same day, the pt received injections of poliomyelitis virus vaccine and measles mumps and rubella virus vaccine. At an unspecified time following the administration of Infanrix, on 03Dec03, the pt experienced swelling of his face and his throat closed. The pt was seen at a physician's office. On an unspecified date the events resolved.
Flank and spinal pain; Flank and spinal pain; Sore at the shot location site; She experienced 24 hours of flu like symptoms; This is a spontaneous report from a non-contactable other healthcare professional. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: expiry date: unknown) via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of the Pfizer COVID vaccine 3 weeks ago. On an unspecified date, the patient had flank and spinal pain that lasted two days after the first dose. She also was sore at the shot location site. After vaccination, she also experienced 24 hours of flu like symptoms and spent a day laying on her couch. Outcome of the events was unknown.  No follow-up attempts are possible. Information about batch/lot number cannot be obtained.
is a rash a side effect of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of RASH (is a rash a side effect of the vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (is a rash a side effect of the vaccine). At the time of the report, RASH (is a rash a side effect of the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. Treatment medication was not provided.
Patient was given the vaccine undiluted in the afternoon of 11/23/2022. Dad reported high fever of 103 around 5-6am the morning after along with body numbness described as "cannot move" and joint pain.  Fever and movement improved one hour after a Tylenol dose. Patient also vomited twice in the morning and again in the evening. In the evening of 11/24, patient has fever again (described as "warm" by Dad) and also stated her arm felt "vibrating."  Dad gave another dose of Tylenol. Patient finally ate something in the evening since the night of vaccine. Morning of 11/25/2022, patient was better and no other symptoms. Parents will keep monitoring.
pt brought to ED via EMS for increasing SOB, cough, chills, O2 sats 80%; positive for COVID; poor appetite; given dexamethasone, Baricitinib, remdesivir, O2 supplementation; code blue called for respiratory arrest; intubated and transferred to ICU; pt didn't improve; condition worsened and she passed away in the hospital
patient stopped having menustration after getting the Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of AMENORRHOEA (patient stopped having menustration after getting the Moderna vaccine) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced AMENORRHOEA (patient stopped having menustration after getting the Moderna vaccine). At the time of the report, AMENORRHOEA (patient stopped having menustration after getting the Moderna vaccine) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment information was reported.  It had been one year since the patient had the last menstrual period.
Patient got dizzy and passed out in her chair while waiting in the lobby after receiving the vaccine.  Pharmacist attended to her had the paramedics called, verified a pulse and breathing and tried to wake her and assured her contined breathing. No rash, or swelling of the throat was noticed and she continues to open her eyes and speak to her husband who was present with her young son. Water was offered to her but 911 suggested no fluids be given until the paramedics took over.  The husband explained to my bilingual technician that when nervous from vaccines she would pass out. Paramedics arrived who took over her care. After there examination she did not leave with them but waited longer in the Pharmacy until she felt stronger and  left under  her own wishes with her husband and son.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 16-FEB-2017 at 09:12, the patient was vaccinated with improperly stored ZOSTAVAX injection (lot # M020902) (expiration date, dose and route of administration were not reported). The vaccine underwent previous temperature excursions. The number of previous excursions, time frames and values of incorrect temperature were unknown. No adverse effects were reported. Digital data logger was used. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1702USA000237: US-009507513-1704USA000485: US-009507513-1704USA000486: US-009507513-1704USA000487: US-009507513-1704USA000488: US-009507513-1704USA000489: US-009507513-1704USA000490: US-009507513-1704USA000491: US-009507513-1704USA000492: US-009507513-1704USA000493: US-009507513-1704USA000494: US-009507513-1704USA000495: US-009507513-1704USA000496: US-009507513-1704USA000498: US-009507513-1704USA000499: US-009507513-1704USA000500: US-009507513-1704USA000501: US-009507513-1704USA000502: US-009507513-1704USA000503: US-009507513-1704USA000504: US-009507513-1704USA000505.
Small pox reaction vaccination , red raised, rash all over body- urticaria, and fever. Follow up report received 05/12/2005:  Patient in transit, condition elevated.  Patient gone from base.
Severe headache, vomiting, visual disturbances, numbness in left hand and left side of face.  Injection site redness with warmth and itching.
Moderate diarrhea on and off beginning 2 days after 2nd dose of vaccination.
Pain in right shoulder and joints on right side of body; Extreme exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727), via an unspecified route of administration in the right arm on 29Mar2021 at 06:45 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included lower back, right hip and knee chronic pain. The patient did not have any allergies to food, medications, or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204), via an unspecified route of administration in the right arm on 08Mar2021 at 11:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 30Mar2021 at 18:00, the patient experienced pain in right shoulder and joints on right side of body. On 30Mar2021 at 18:45, the patient experienced extreme exhaustion that began 24 hours after second dose. The events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events pain in right shoulder and joints on right side of body and extreme exhaustion. The clinical outcomes of the events pain in right shoulder and joints on right side of body and extreme exhaustion were not resolved at the time of the report.   No follow-up attempts are needed. No further information is expected.
Moderna COVID-19 Vaccine EUA.  Allergic reaction approximately 1-1.5 hours after receiving first dose of Moderna COVID-19 vaccine. Itchy eyes, nose, roof of mouth. Sneezing and congestion. Blotchy/rashy/itchy neck. Took a Benadryl approximately 2 hours after receiving the dose. Fell asleep for approximately 1.5 hours and most symptoms had subsided by the time I woke up.
Patient received SHINGRIX and then later that day she started having a lot of body aches/muscle pains in the legs. She said she was in bed for a couple days because of the pain. Patient stated that she also felt a little flu-like.
Pt recvd vax & w/in 48 hrs devel a total body rash; urticaria dx by MD;
Information has been received from a Physician Assistant concerning an 81 year old female patient with hypertension, hyperlipidaemia, osteoporosis, gastroesophageal reflux disease, coronary artery disease, CLARITIN allergy, BENADRYL allergy and allergic reaction to tetracycline who in approximately 2007 was vaccinated with ZOSTAVAX (Lot # not reported). Concomitant therapy included PRILOSEC (indication not reported), ACCUPRIL, ACTONEL, aspirin, LIPITOR, LOPRESSOR and PLAVIX. On 15-JAN-2009 the patient experienced shingles. She was experiencing a vesicular rash from her mid abdomen to her side which extends around her flank area to her mid- lumbar area. It does not cross the mid- line. She had redness, erythema and severe burning. There was no streaking and no pus. The patient has been prescribed VALTREX and LYRICA. As of today on 19-JAN-2009, the pain was improving but the rash had remained the same. There were no Laboratory Diagnostics Studies performed. The patient sought unspecified medical attention at the office visit. Additional information has been requested.
Within 5 hours - headache, chills, later that evening chills alternating with hot flashes, extreme fatigue, headache, nausea, body aches
Tested Positive for COVID 19 4/21/2021  Wife tested COVID positive 4/16/2021 Runny nose started 4/21/2021
Vaccine underdose; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (Vaccine underdose) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced UNDERDOSE (Vaccine underdose) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (Vaccine underdose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (Vaccine underdose).    Concomitant medications were not reported.                                       No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live non-significant follow up appended
Extremely dizzy.  Lost balance and fell down a few times just trying to walk to the bathroom. Many other times felt like about to pass out or loose consciousness.  Still dizzy at times especially when bending over to pick things up. Not back to normal.  Thought about going to see a Dr. about it but read online that dizziness seems to be rampant with J and J shot.
Narrative: 88yo male with h/o Major Neurocognitive Disorder ,alcohol use do,in remission, Past Medical hx significant for CHF,CAD,HTN,HLD, and spinal stenosis died on7/8/21. Pt had been vaccinated with covid vaccine on 1/16/21 & 2/13/21. Most recent medical entries related to mental health issues. No information about pt's death provided in pt's chart. Likely death is not related to vaccinations given the long timeframe btwn the death and date of vaccinations.
Administration of Improperly Stored Vaccine; Respiratory Illness; This case was reported by a consumer via call center representative and described the occurrence of respiratory disorder in a 6-month-old male patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Pediarix (received 1st dose on 4th March 2022). Concomitant products included PEDIARIX.   On 12th July 2022, the patient received the 3rd dose of Pediarix and Pediarix Pre-Filled Syringe Device. On 28th July 2022, 16 days after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced respiratory disorder. On an unknown date, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the respiratory disorder was not recovered/not resolved and the outcome of the incorrect storage of drug was unknown.   It was unknown if the reporter considered the respiratory disorder to be related to Pediarix and Pediarix Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 01-Sept-2022 Reporter's comment: The member of public reported that the patient (her grandson) received third dose of Pediarix vaccine and the family then received a message that the vaccine had not been properly stored, that the temperature monitoring system had not been working for the past 3 months and was not discovered until 9th May 2022.   The message stated that the office wanted to repeat the dose of the vaccine, but the reporter was concerned about this because the patient has had a respiratory illness for the past 5 weeks. The reporter did not had the lot number information for any doses. The reporter was unsure if the health care professional office reported this event, could potentially be a duplicate. The reporter stated that she was unsure about giving permission for follow-up and did not knew the health care professional's information. Additional supportive information: The patient received the third dose after temperature excursion, which led to incorrect storage of drug.
Phone Call: c/o red welts from injection area to knee. Referred to family MD.
1ST DOSE -- SORE ARM, NUMB FINGERTIPS. 2ND DOSE - SORE ARM, HARD INJECTION SITE FOR 4 DAYS SO FAR, ITCHY INJECTION SITE ON DAYS 2-4.
My daughter spiked a fever of 101 at 4:00 pm so I gave her Tylenol.  At 8:00 pm I checked her temperature and it was 99.0.  At 8:20 we were placing her in her crib and she began to have a seizure that lasted 4 minutes.  When the seizure was over her temperature was assessed and was 104.  After a trip to the emergency room we were sent home.  Then at 4:00am she had another seizure when her fever spiked again.
rash that ended up in shingles; rash that ended up in shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (rash that ended up in shingles) and RASH (rash that ended up in shingles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (rash that ended up in shingles) and RASH (rash that ended up in shingles). At the time of the report, HERPES ZOSTER (rash that ended up in shingles) and RASH (rash that ended up in shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant and treatment medications were reported.
Feeling of flushing/warmth from head to toe, mild itching throughout body, and dizziness/lightheaded.  Blood pressure was elevated >180/90, HR 110-120.  Gradually decreased and at approximately 30minutes post injection, blood pressure was <145/90 and HR 84.  Took 25mg of benadryl approximately 1 1/2 hour after injection time. Symptoms persisted mildly for another 30-45 minutes after benadryl and seem to be gone 5 hours later. Blood pressure 5 hours after was 134/85 which is still a slight elevation from my norm.
I got diagnosed with Covid 19 on 26Jun2021. My parents were diagnosed with Covid 19 on the same day.; I got diagnosed with Covid 19 on 26Jun2021. My parents were diagnosed with Covid 19 on the same day.; This is a spontaneous report from a Pfizer sponsored program. This consumer for a female patient (reporters mother) that: A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on Feb2021 as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 26Jun2021, the patient experienced i got diagnosed with covid 19 on 26jun2021, my parents were diagnosed with covid 19 on the same day. It was reported that his whole family was vaccinated with the Covid 19 vaccine by Pfizer since Feb2021. MD says we had the virus breakthrough. It seemed to be happened to many people in the (with held) and just wanted you to be aware. The patient underwent lab tests and procedures which included COVID-19: positive, got diagnosed with Covid 19 on 26Jun2021. Events were considered serious (medically significant). The clinical outcome of events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021884456 Same reporter/drug/AE, different patient.
Nausea, fever, headache, bad taste in mouth, breasts sore, nipples sore or hurt, low stomach cramping,
I have a high platelet level and inflammation from the vaccine caused blood flow problems resulting in trouble thinking clearly as well as walking.
Developed neurological systems starting 4/12/31, worsening over 2 weeks -- face tingling, leg tingling, full body nerve pain, muscle weakness (developed difficulty walking, grasping, etc), nausea, inability to regulate body temperature, heart rate fluctuations
Rapid heart rate; Fever; Chills; Body aches; This spontaneous case was reported by a nurse and describes the occurrence of HEART RATE INCREASED (Rapid heart rate), CHILLS (Chills), MYALGIA (Body aches) and PYREXIA (Fever) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unk) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Dec-2020, the patient experienced CHILLS (Chills) and MYALGIA (Body aches). On 29-Dec-2020, the patient experienced HEART RATE INCREASED (Rapid heart rate) and PYREXIA (Fever). At the time of the report, HEART RATE INCREASED (Rapid heart rate), CHILLS (Chills), MYALGIA (Body aches) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Dec-2020, Heart rate: 72 72 heart beats per minute. On 29-Dec-2020, Oxygen saturation: normal (normal) normal. On 29-Dec-2020, Vital signs measurement: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Reporter's Comments: This case concerns a 64-year-old male who experienced a NS unexpected event of heart rate increased and nonserious expected events of pyrexia, chills, and myalgia. Event onset was the same day as the first dose of mRNA-1273. Treatment included acetaminophen. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
10 minutes after receiving the vaccine the patient began to vomit, stated her throat felt scratchy, face became flushed. patient taken to the ER
developed a rash basically on my face and neck/It was around my face and collar area; I was also short of breath, feeling breathless and my face was swollen.; I was also short of breath, feeling breathless and my face was swollen.; This is a spontaneous report received from a contactable consumer (Patient). A 74-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6205), via an unspecified route of administration on 24Feb2021 as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that She received her first dose on 24Feb2021 and about a week later she "developed a rash basically on my face and neck. I thought it might be something that I was using like soap or detergent, but I hadn't changed anything of that. It was around my face and collar area. I did go to the doctor just in case it was shingles and he said that it wasn't. It did resolve on its own and eventually got better. I used Vaseline to rub on the rash and that helped." The caller states that she received her second dose on 17Mar2021, and she reports, "about a week and a half later the same type of rash showed up on my face and neck area. This time it was worse than the first time to the point that my ear lobe was weeping. I was also short of breath, feeling breathless and my face was swollen. When the rash was the worst the breathing was also worse. It does seem to be going away and it's getting better now. she was not really looking for any particular answers, but she felt that it was important to call and report her reaction. The outcome of the events was recovering.   No follow-up attempts are needed. No further information is expected.